Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 31.67B | 32.94B | 30.60B | 31.11B | 35.65B |
Gross Profit | 6.57B | 6.66B | 6.40B | 5.90B | 6.36B |
EBITDA | 1.90B | 1.79B | 1.73B | 398.00M | 1.38B |
Net Income | 851.00M | 840.00M | 758.00M | -1.34B | 382.00M |
Balance Sheet | |||||
Total Assets | 31.49B | 29.89B | 28.97B | 29.61B | 30.96B |
Cash, Cash Equivalents and Short-Term Investments | 6.32B | 6.20B | 5.69B | 4.93B | 40.00M |
Total Debt | 3.28B | 3.24B | 3.73B | 4.88B | 3.70B |
Total Liabilities | 14.10B | 14.07B | 14.04B | 15.56B | 15.73B |
Stockholders Equity | 17.26B | 15.70B | 14.80B | 13.92B | 15.10B |
Cash Flow | |||||
Free Cash Flow | 101.00M | 1.26B | 762.00M | -1.21B | -83.00M |
Operating Cash Flow | 1.25B | 2.23B | 1.61B | 68.00M | 727.00M |
Investing Cash Flow | -627.00M | -772.00M | 651.00M | -1.25B | -856.00M |
Financing Cash Flow | -600.00M | -900.00M | -1.64B | 672.00M | -244.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $792.76B | 18.47 | 5.58% | 4.66% | -0.72% | -63.97% | |
74 Outperform | $3.03T | 36.97 | 5.46% | 4.34% | 14.29% | 368.64% | |
74 Outperform | $4.18T | 10.40 | 15.51% | 1.59% | 10.17% | 226.18% | |
71 Outperform | ¥8.49B | 6.08 | 3.19% | 9.10% | 76.73% | ||
70 Outperform | ¥10.75T | 27.21 | 21.48% | 1.66% | 10.29% | 11.37% | |
66 Neutral | $7.11T | 51.45 | 1.99% | 4.34% | 1.52% | -8.68% | |
66 Neutral | ¥495.00B | 16.63 | 1.15% | 2.18% | 6.46% | -14.78% |